| Steven M Standaert, MD | |
|
3525 Ensign Rd Ne Ste R, Pmg Sw Wa Olympia Infectious Diseases, Olympia, WA 98506-5065 | |
| (360) 493-4001 | |
| Not Available |
| Full Name | Steven M Standaert |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 40 Years |
| Location | 3525 Ensign Rd Ne Ste R, Olympia, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750455317 | NPI | - | NPPES |
| 1111459 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD00038050 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Peter Hospital | Olympia, WA | Hospital |
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 6709782600 | 393 |
News Archive
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
Moffitt Cancer Center researchers suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy with other inhibitors, especially as they become more widely used.
The New England Regional Spinal Cord Injury Center at Boston Medical Center (BMC) has been selected as a Spinal Cord Injury Model System (SCIMS) by the National Institute on Disability and Rehabilitation Research.
Digital Pathology is happening. While the advantages are evident and experts already predict a new generation of pathologists, only few laboratories and institutes have started planning and investing in fully digital work-flows. At the same time, the demand for professional online exchange and a convenient way of sharing educational or rare cases is growing with the aim to support a more precise and profound health care.
› Verified 2 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
Moffitt Cancer Center researchers suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy with other inhibitors, especially as they become more widely used.
The New England Regional Spinal Cord Injury Center at Boston Medical Center (BMC) has been selected as a Spinal Cord Injury Model System (SCIMS) by the National Institute on Disability and Rehabilitation Research.
Digital Pathology is happening. While the advantages are evident and experts already predict a new generation of pathologists, only few laboratories and institutes have started planning and investing in fully digital work-flows. At the same time, the demand for professional online exchange and a convenient way of sharing educational or rare cases is growing with the aim to support a more precise and profound health care.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven M Standaert, MD Po Box 3360, Portland, OR 97208-3360 Ph: (866) 747-2455 | Steven M Standaert, MD 3525 Ensign Rd Ne Ste R, Pmg Sw Wa Olympia Infectious Diseases, Olympia, WA 98506-5065 Ph: (360) 493-4001 |
News Archive
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 3 study of D-tagatose as a monotherapy in Type 2 diabetes showed a statistically significant (p<0.05) reduction in HbA1c levels of 0.4% at 10 months in relatively healthy people with diabetes
Moffitt Cancer Center researchers suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy with other inhibitors, especially as they become more widely used.
The New England Regional Spinal Cord Injury Center at Boston Medical Center (BMC) has been selected as a Spinal Cord Injury Model System (SCIMS) by the National Institute on Disability and Rehabilitation Research.
Digital Pathology is happening. While the advantages are evident and experts already predict a new generation of pathologists, only few laboratories and institutes have started planning and investing in fully digital work-flows. At the same time, the demand for professional online exchange and a convenient way of sharing educational or rare cases is growing with the aim to support a more precise and profound health care.
› Verified 2 days ago
Miss Tui Agaapapalagi Lauilefue, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3920 Capital Mall Dr Sw Ste 200, Olympia, WA 98502 Phone: 360-596-4899 Fax: 360-596-4889 | |
Monique C. Semien, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 Fax: 360-923-7089 | |
Colleen M Overdorf, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Lilly Rd Ne Ste 201, Olympia, WA 98506 Phone: 360-413-8272 | |
Dr. Philip William Berger, D.O. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 406 Black Hills Ln Sw, Ste A, Olympia, WA 98502 Phone: 360-754-1737 Fax: 360-704-3408 | |
Mr. Robert Love Huck, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 500 Lilly Rd Ne Suite 201, Olympia, WA 98503 Phone: 360-413-8272 Fax: 360-413-8878 | |
Dr. Ngozi Achebe, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3900 Capitol Mall Dr Sw, Sw, Olympia, WA 98502 Phone: 360-754-5858 Fax: 360-704-4751 | |
Dr. Robert C Tomford, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 500 Lilly Rd Ne, Suite 203, Olympia, WA 98506 Phone: 360-413-8121 Fax: 360-413-8865 |